Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-Shaw

It looks to build a pipeline of 28 biosimilars across global markets in three phases.

from Stocks-Markets-Economic Times https://ift.tt/30ThpQ6

Comments

Popular posts from this blog